Skip Navigation


Hum. Reprod. Advance Access originally published online on July 22, 2009
Human Reproduction 2009 24(11):2676-2678; doi:10.1093/humrep/dep258
This Article
Right arrow Full Text
Right arrow Full Text (PDF )
Right arrow All Versions of this Article:
24/11/2676    most recent
dep258v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Hum. Reprod.
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lutgens, S. P.M.
Right arrow Articles by Dunselman, G. A.J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lutgens, S. P.M.
Right arrow Articles by Dunselman, G. A.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

New debate

To do or not to do: IVF and ICSI in chronic hepatitis B virus carriers

Suzanne P.M. Lutgens1,{dagger}, Ewka C.M. Nelissen2,4,{dagger}, Inge H.M. van Loo1, Ger H. Koek3, Josien G. Derhaag2 and Gerard A.J. Dunselman2

1 Department of Medical Microbiology, Research Institute Growth & Development (GROW), Maastricht University Medical Centre, P. Debyelaan 25, 6202 AZ Maastricht, The Netherlands 2 Department of Obstetrics and Gynaecology, Research Institute Growth & Development (GROW), Maastricht University Medical Centre, P. Debyelaan 25, 6202 AZ Maastricht,, The Netherlands 3 Department of Internal Medicine, Division of Gastroenterology and Hepatology, Research Institute Growth & Development (GROW), Maastricht University Medical Centre, P. Debyelaan 25, 6202 AZ Maastricht, The Netherlands

4 Correspondence address. Tel: +31-43-3876764; Fax: +31-43-3874765; E-mail: e.nelissen{at}mumc.nl

Several assisted reproduction procedures, such as IVF and ICSI, are available for a variety of infertility problems. In fertility clinics, patients are screened for blood-borne viral infections, including hepatitis B virus (HBV). Reasons for screening are prevention of vertical transmission and laboratory safety. We present the case of a 26-year-old female patient with a chronic HBV infection, whose husband tested negative for hepatitis B. She and her husband were referred to our fertility clinic because of subfertility. Analysis of the husband's semen indicated the necessity of an ICSI procedure. The current Dutch guidelines advise against ICSI in chronic HBV carriers, since the risks and effects of chromosomal integration of HBV DNA in the fetus are not well-known. In this article, we review the scientific evidence for the risk of introducing HBV virus into the oocyte and subsequent integration of HBV DNA into the human genome, and debate the question of whether to do, or not to do, IVF and ICSI.

Key words: hepatitis B/IVF/ICSI/quality control/vertical transmission

{dagger} Both authors contributed equally


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Hum. Reprod.:

Editor's Choice
André Van Steirteghem
Hum. Reprod. 2009 24: 2675. [Extract] [Full Text]  





Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.